Leaflet AXID 25mg / ml concentrate for solution for infusion

Product code:
W04599001
Quantity:
5
Indicated for:
peptic ulcer; gastroesophageal reflux
Route of administration:
infusion
Substance:
nizatidine (H2 receptor antagonist)
ATC
A02BA04 — Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | H2-receptor antagonists
Nizatidine is an H2 receptor antagonist used in the treatment of gastric and duodenal ulcers, as well as gastroesophageal reflux disease (GERD). It works by reducing the production of gastric acid.

The medication is administered orally, as directed by a doctor, usually once or twice daily. It is important for patients to follow the treatment regimen and avoid alcohol or foods that may worsen symptoms.

Patients should be aware of potential side effects, such as headaches, nausea, or diarrhea. It is important to inform the doctor of any unusual symptoms.

Common side effects include headaches, nausea, and diarrhea. In rare cases, severe reactions such as hepatotoxicity or allergic reactions may occur. Patients should be informed of these risks before use.

General data about AXID 25mg / ml

Substance:
nizatidine
Date of latest medicines list:
01-07-2013
Product code:
W04599001
Concentration:
25mg / ml
Pharmaceutical form:
concentrate for solution for infusion
Quantity:
5
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Pharmaceutical forms available for nizatidine

Concentrations available for nizatidine

  • 150mg
  • 25mg/ml
  • 300mg